Document is current

Any future updates will be listed below

Comparative efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors versus tyrosine kinase inhibitors and immune checkpoint inhibitors alone in advanced hepatocellular carcinoma: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12957-025-03788-0

Published Online: 2025-04-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark